7ZH8 | pdb_00007zh8

DYRK1a in Complex with a Bromo-Triazolo-Pyridine


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.235 (Depositor), 0.237 (DCC) 
  • R-Value Work: 
    0.199 (Depositor), 0.199 (DCC) 
  • R-Value Observed: 
    0.199 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7ZH8

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Screening of a Halogen-Enriched Fragment Library Leads to Unconventional Binding Modes.

Dammann, M.Stahlecker, J.Zimmermann, M.O.Klett, T.Rotzinger, K.Kramer, M.Coles, M.Stehle, T.Boeckler, F.M.

(2022) J Med Chem 65: 14539-14552

  • DOI: https://doi.org/10.1021/acs.jmedchem.2c00951
  • Primary Citation Related Structures: 
    7ZH8

  • PubMed Abstract: 

    We conceived the Halogen-Enriched Fragment Library (HEFLib) to investigate the potential of halogen bonds in the early stages of drug discovery. As the number of competitive interactions increases with ligand size, we reasoned that a binding mode relying on halogen bonding is more likely for fragments than highly decorated molecules. Thus, fragments could feature unexplored binding modes. We screened the HEFLib against the human kinase DYRK1a and verified micromolar binding fragments via isothermal titration calorimetry (ITC). The crystal structure of one fragment revealed a noncanonical binding mode, despite the fragment's classical hinge binding motif. In addition, the fragment occupies a secondary binding site. Both binding modes feature a halogen bond, which we evaluated by ab initio calculations. Structure-affinity relationship (SAR) from a set of analogues improves the affinity, provides a promising fragment-growth vector, and highlights the benefits and applicability of halogen bonds in early lead development.


  • Organizational Affiliation
    • Laboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076Tübingen, Germany.

Macromolecule Content 

  • Total Structure Weight: 185.02 kDa 
  • Atom Count: 12,103 
  • Modeled Residue Count: 1,387 
  • Deposited Residue Count: 1,528 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Dual specificity tyrosine-phosphorylation-regulated kinase 1A
A, B, C, D
382Homo sapiensMutation(s): 0 
Gene Names: DYRK1ADYRKMNBMNBH
EC: 2.7.12.1 (PDB Primary Data), 2.7.11.23 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for Q13627 (Homo sapiens)
Explore Q13627 
Go to UniProtKB:  Q13627
PHAROS:  Q13627
GTEx:  ENSG00000157540 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ13627
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 9 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
EPE

Query on EPE



Download:Ideal Coordinates CCD File
AB [auth D],
EA [auth B],
L [auth A],
SA [auth C]
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
C8 H18 N2 O4 S
JKMHFZQWWAIEOD-UHFFFAOYSA-N
1PE

Query on 1PE



Download:Ideal Coordinates CCD File
DA [auth B],
M [auth A]
PENTAETHYLENE GLYCOL
C10 H22 O6
JLFNLZLINWHATN-UHFFFAOYSA-N
IWU
(Subject of Investigation/LOI)

Query on IWU



Download:Ideal Coordinates CCD File
E [auth A]
G [auth A]
KA [auth C]
MA [auth C]
V [auth B]
E [auth A],
G [auth A],
KA [auth C],
MA [auth C],
V [auth B],
W [auth B],
WA [auth D],
XA [auth D]
6-bromanyl-3H-[1,2,3]triazolo[4,5-b]pyridine
C5 H3 Br N4
YKWWQNVTTSHHGH-UHFFFAOYSA-N
PG4

Query on PG4



Download:Ideal Coordinates CCD File
F [auth A],
LA [auth C]
TETRAETHYLENE GLYCOL
C8 H18 O5
UWHCKJMYHZGTIT-UHFFFAOYSA-N
PGE

Query on PGE



Download:Ideal Coordinates CCD File
I [auth A],
J [auth A],
RA [auth C],
ZA [auth D]
TRIETHYLENE GLYCOL
C6 H14 O4
ZIBGPFATKBEMQZ-UHFFFAOYSA-N
PEG

Query on PEG



Download:Ideal Coordinates CCD File
H [auth A]
JA [auth C]
NA [auth C]
OA [auth C]
Y [auth B]
H [auth A],
JA [auth C],
NA [auth C],
OA [auth C],
Y [auth B],
YA [auth D]
DI(HYDROXYETHYL)ETHER
C4 H10 O3
MTHSVFCYNBDYFN-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
BB [auth D]
CB [auth D]
DB [auth D]
FA [auth B]
GA [auth B]
BB [auth D],
CB [auth D],
DB [auth D],
FA [auth B],
GA [auth B],
HA [auth B],
N [auth A],
O [auth A],
P [auth A],
Q [auth A],
R [auth A],
TA [auth C],
UA [auth C]
SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L
GOL

Query on GOL



Download:Ideal Coordinates CCD File
AA [auth B]
BA [auth B]
CA [auth B]
K [auth A]
PA [auth C]
AA [auth B],
BA [auth B],
CA [auth B],
K [auth A],
PA [auth C],
QA [auth C],
X [auth B],
Z [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
IA [auth B],
S [auth A],
T [auth A],
U [auth A],
VA [auth C]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
PTR
Query on PTR
A, B, C, D
L-PEPTIDE LINKINGC9 H12 N O6 PTYR

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.235 (Depositor), 0.237 (DCC) 
  • R-Value Work:  0.199 (Depositor), 0.199 (DCC) 
  • R-Value Observed: 0.199 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 245.004α = 90
b = 64.663β = 115.577
c = 147.308γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
Cootmodel building
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2022-11-09
    Type: Initial release
  • Version 1.1: 2022-11-23
    Changes: Database references
  • Version 1.2: 2024-01-31
    Changes: Data collection, Refinement description
  • Version 1.3: 2024-10-23
    Changes: Structure summary